SCHEMBL2203380

SCHEMBL2203380

CCCN(CCC)CCCCNCc1ccc(CN=Cc2ccc(C)o2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.39
HRH4 Q9H3N8 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
CHRM2 P08172 3/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
CA1 P00915 1/20 0.33
ALDH1A1 P00352 4/20 0.33
PKM P14618 2/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
S1PR2 O95136 1/20 0.32
S1PR4 O95977 1/20 0.32
S1PR1 P21453 1/20 0.32
S1PR3 Q99500 1/20 0.32
MAPT P10636 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2203504 0.82 ALDH1A1 (0.39) HRH3POLBALDH1A1PKMMAPT
SCHEMBL2204041 0.82 CXCR4 (0.41) CXCR4HRH4HRH3CHRM2SMN1; SMN2
SCHEMBL4947488 0.81 POLB (0.35) CYP1A2POLBCA1ALDH1A1PKM
SCHEMBL14007955 0.81 CXCR4 (0.40) CXCR4HRH4HRH3CHRM2SMN1; SMN2
SCHEMBL2203375 0.79 KDM4E (0.34) CYP1A2POLBCA1ALDH1A1PKM
SCHEMBL2202386 0.78 CHRM2 (0.50) CXCR4HRH4HRH3CHRM2LMNA
SCHEMBL2203507 0.78 KDM4E (0.33) POLBALDH1A1PKMMAPTKDM4E
SCHEMBL2202962 0.77 SCN8A (0.40) CXCR4HRH4HRH3CHRM2SMN1; SMN2
SCHEMBL2204056 0.75 CXCR4 (0.54) CXCR4HRH4HRH3CHRM2SMN1; SMN2
SCHEMBL12510185 0.75 HRH4 (0.47) CXCR4HRH4HRH3CHRM2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977512-B2 Amine derivative, and production method and use thereof KUREHA CORPORATION (JP) 2011-07-12 US disclosed
US-7977512-B2 Amine derivative, and production method and use thereof KUREHA CORPORATION (JP) 2011-07-12 US disclosed
US-7977512-B2 Amine derivative, and production method and use thereof KUREHA CORPORATION (JP) 2011-07-12 US disclosed
US-20080293951-A1 Amin Derivative, and Production Method and Use Thereof KUREHA CORPORATION 2008-11-27 US disclosed
US-20080293951-A1 Amin Derivative, and Production Method and Use Thereof KUREHA CORPORATION 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293951-A1 Amin Derivative, and Production Method and Use Thereof BCAT2, BCAT1, MRPL9 CXCR4 2546/4885HRH4 52/4885HRH3 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.